Beta Bionics Inc(US:BBNX) Globenewswire·2026-01-23 15:20Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Beta Bionics, Inc. due to significant stock losses and possible misleading statements made by the company [4][5]. Group 1: Company Overview - Beta Bionics, Inc. is listed on NASDAQ under the ticker BBNX [4]. - The company experienced a significant stock price decline of approximately 37% on January 9, 2026, following an announcement regarding lower-than-expected patient starts for the fourth quarter [5]. Group 2: Legal Investigation - The investigation by Faruqi & Faruqi focuses on whether Beta Bionics issued misleading statements or failed to disclose important information relevant to investors [5]. - Faruqi & Faruqi has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [4].